Modulation of eiF4E-BP2 expression

Details for Australian Patent Application No. 2006318194 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Jain, Ravi; Dobie, Kenneth W.; Bhanot, Sanjay

Agent Davies Collison Cave

Pub. Number AU-B-2006318194

PCT Pub. Number WO2007/062380

Priority 60/739,106 21.11.05 US

Filing date 21 November 2006

Wipo publication date 31 May 2007

Acceptance publication date 9 August 2012

International Classifications

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/062380 Priority application(s): WO2007/062380

9 August 2012 Application Accepted

  Published as AU-B-2006318194

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006318206-Method of solution preparation of polyolefin class polymers for electrospinning processing included

2006318155-Chimeric, hybrid and tandem polypeptides of meningococcal NMB 1870